Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Macrolides in chronic inflammatory skin disorders.

Alzolibani AA, Zedan K.

Mediators Inflamm. 2012;2012:159354. doi: 10.1155/2012/159354. Epub 2012 May 17. Review.

2.

Chronic macrolide therapy in inflammatory airways diseases.

Friedlander AL, Albert RK.

Chest. 2010 Nov;138(5):1202-12. doi: 10.1378/chest.10-0196. Review.

PMID:
21051396
3.

Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases.

Rodriguez-Cerdeira C, Sanchez-Blanco E, Molares-Vila A.

Mediators Inflamm. 2012;2012:563709. doi: 10.1155/2012/563709. Epub 2012 Nov 1. Review.

5.

[Oral antibiotics with antiinflammatory/ immunomodulatory effects in the treatment of various dermatoses].

Brinkmeier T, Frosch PJ.

Hautarzt. 2002 Jul;53(7):456-65. Review. German.

PMID:
12219268
6.

[Usefulness of macrolides as anti-inflammatories in respiratory diseases].

Sevilla-Sánchez D, Soy-Muner D, Soler-Porcar N.

Arch Bronconeumol. 2010 May;46(5):244-54. doi: 10.1016/j.arbres.2009.10.008. Epub 2009 Dec 4. Review. Spanish.

7.

Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.

Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC.

Clin Exp Allergy. 2012 Sep;42(9):1302-12. doi: 10.1111/j.1365-2222.2012.03979.x. Review.

PMID:
22925316
8.

Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics.

Steel HC, Theron AJ, Cockeran R, Anderson R, Feldman C.

Mediators Inflamm. 2012;2012:584262. doi: 10.1155/2012/584262. Epub 2012 Jun 21. Review.

9.

Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.

Shimizu T, Suzaki H.

Auris Nasus Larynx. 2016 Apr;43(2):131-6. doi: 10.1016/j.anl.2015.08.014. Epub 2015 Oct 4. Review.

PMID:
26441370
10.

Clinical implications of the immunomodulatory effects of macrolides.

Tamaoki J, Kadota J, Takizawa H.

Am J Med. 2004 Nov 8;117 Suppl 9A:5S-11S. Review.

PMID:
15586558
11.

Anti-inflammatory activity of tetracyclines.

Webster G, Del Rosso JQ.

Dermatol Clin. 2007 Apr;25(2):133-5, v. Review.

PMID:
17430750
12.
13.

Macrolides in cystic fibrosis.

Bell SC, Senini SL, McCormack JG.

Chron Respir Dis. 2005;2(2):85-98. Review.

PMID:
16279156
14.

Anti-inflammatory capabilities of macrolides.

Zalewska-Kaszubska J, Górska D.

Pharmacol Res. 2001 Dec;44(6):451-4. Review.

PMID:
11735349
15.

Immunomodulatory effects of macrolides: implications for practicing clinicians.

Siddiqui J.

Am J Med. 2004 Nov 8;117 Suppl 9A:26S-29S. Review.

PMID:
15586561
16.

Diffuse panbronchiolitis: role of macrolides in therapy.

Keicho N, Kudoh S.

Am J Respir Med. 2002;1(2):119-31. Review.

PMID:
14720066
17.

The role of atypical infections and macrolide therapy in patients with asthma.

Rollins DR, Good JT Jr, Martin RJ.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):511-7. doi: 10.1016/j.jaip.2014.06.002. Epub 2014 Aug 3. Review.

PMID:
25213043
18.

Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis.

Schultz MJ.

J Antimicrob Chemother. 2004 Jul;54(1):21-8. Epub 2004 Jun 9. Review.

PMID:
15190022
20.

Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.

Shinkai M, Henke MO, Rubin BK.

Pharmacol Ther. 2008 Mar;117(3):393-405. doi: 10.1016/j.pharmthera.2007.11.001. Epub 2007 Dec 15. Review.

PMID:
18289694

Supplemental Content

Support Center